Advanced search
Publication Cover
Drug Delivery Volume 24, 2017 - Issue 1
Submit an article Journal homepage
3,721
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Which inhaled corticosteroid and long-acting β-agonist combination is better in patients with moderate-to-severe asthma, a dry powder inhaler or a pressurized metered-dose inhaler?

Masato Murakia Department of Respiratory Medicine and Allergology, Kindai University Nara Hospital, Ikoma, Japan; Correspondence[email protected]
,
Kyuya Gosea Department of Respiratory Medicine and Allergology, Kindai University Nara Hospital, Ikoma, Japan;
,
Soichiro Hanadaa Department of Respiratory Medicine and Allergology, Kindai University Nara Hospital, Ikoma, Japan;
,
Hirochiyo Sawaguchia Department of Respiratory Medicine and Allergology, Kindai University Nara Hospital, Ikoma, Japan;
&
Yuji Tohdab Department of Respiratory Medicine and Allergology, Kindai University Faculty of Medicine, Osakasayama, Japan
Pages 1395-1400 | Received 16 Jul 2017, Accepted 09 Sep 2017, Published online: 20 Sep 2017

References

  • Abe Y, Shibata Y, Igarashi A, et al. (2016). Reference values of MostGraph measures for middle-aged and elderly Japanese individuals who participated in annual health checkups. Respir Investig 54:148–55.
  • Arioka H, Kobayashi K, Kudo K, et al. (2005). Validation study of a disease-specific module, the Asthma Health Questionnaire (AHQ) using Japanese adult asthmatic patients. Allergol Int 54:473–82.
  • Darbà J, Ramírez G, Sicras A, et al. (2016). Identification of factors involved in medication compliance: incorrect inhaler technique of asthma treatment leads to poor compliance. Patient Prefer Adherence 10:135–45.
  • Dolovich MB, Ahrens RC, Hess DR, et al. (2005). Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest 127:335–71.
  • Global Initiative for Asthma (GINA). 2017. GINA Report, Global Strategy for Asthma Management and Prevention. Available at: http://ginasthma.org.
  • Harnan SE, Tappenden P, Essat M, et al. (2015). Measurement of exhaled nitric oxide concentration in asthma: a systematic review and economic evaluation of NIOX MINO, NIOX VERO and NObreath. Health Technol Assess 19:1–330.
  • Ichinose M, Sugiura H, Nagase H, et al. (2017). Japanese guidelines for adult asthma 2017. Allergol Int 66:163–89.
  • Kawamatawong T, Khiawwan S, Pornsuriyasak P. (2017). Peak inspiratory flow rate measurement by using In-Check DIAL for the different inhaler devices in elderly with obstructive airway diseases. J Asthma Allergy 10:17–21.
  • Miyahara H, Korematsu S, Nagakura T, et al. (2008). Efficacy of fluticasone metered-dose inhaler and dry powder inhaler for pediatric asthma. Pediatr Int 50:103–8.
  • Molimard M, Raherison C, Lignot S, et al. (2003). Assessment of handling of inhaler devices in real life: an observational study in 3811 patients in primary care. J Aerosol Med 16:249–54.
  • Muraki M, Ichihashi H, Haraguchi R, et al. (2008). Comparison of the Asthma Health Questionnaire-33-Japan and the short-form 36-item health survey for measuring quality of life in Japanese patients with asthma. Allergol Int 57:339–46.
  • Nolte H, Pavord I, Backer V, et al. (2013). Dose-dependent anti-inflammatory effect of inhaled mometasone furoate/formoterol in subjects with asthma. Respir Med 107:656–64.
  • Price D, Roche N, Christian Virchow J, et al. (2011). Device type and real-world effectiveness of asthma combination therapy: an observational study. Respir Med 105:1457–66.
  • Schatz M, Kosinski M, Yarlas AS, et al. (2009). The minimally important difference of the Asthma Control Test. J Allergy Clin Immunol 124:719–23.
  • Shirai T, Kurosawa H. (2016). Clinical application of the forced oscillation technique. Intern Med 55:559–66.
  • Sicras A, Ferrer V, Collar JM, et al. (2016). Persistence to treatment by type of inhaler device in patients with asthma and chronic obstructive pulmonary disease. Semergen 43:375–86. [Spanish]
  • Thomas M, Kay S, Pike J, et al. (2009). The Asthma Control Test (ACT) as a predictor of GINA guideline-defined asthma control: analysis of a multinational cross-sectional survey. Prim Care Respir J 18:41–9.
  • Tohda Y, Iwanaga T, Sano H, et al. (2017). Improved quality of life in asthma patients under long-term therapy: assessed by AHQ-Japan. Int J Clin Pract 71:e12898.
  • van der Palen J. (2003). Peak inspiratory flow through Diskus and Turbuhaler, measured by means of a peak inspiratory flow meter (In-Check DIAL). Respir Med 97:285–9.
  • van Noord JA, Lill H, Carillo Diaz T, et al. (2001). Clinical equivalence of a salmeterol/fluticasone propionate combination product (50/500µg) delivered via a chlorofluorocarbon-free metered-dose inhaler with the Diskus™ in patients with moderate to severe asthma. Clin Drug Invest 21:243–55.
  • Virchow JC, Crompton GK, Dal Negro R, et al. (2008). Importance of inhaler devices in the management of airway disease. Respir Med 102:10–19.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.